Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Iradimed (IRMD) Accumulated Depreciation & Amortization (2016 - 2025)

Iradimed (IRMD) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $4.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 9.11% to $4.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.9 million, a 9.11% increase, with the full-year FY2024 number at $4.6 million, up 12.92% from a year prior.
  • Accumulated Depreciation & Amortization was $4.9 million for Q3 2025 at Iradimed, roughly flat from $4.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.9 million in Q3 2025 to a low of $134870.0 in Q1 2022.
  • A 5-year average of $2.2 million and a median of $2.5 million in 2021 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 94.53% in 2022, then skyrocketed 2570.51% in 2024.
  • Iradimed's Accumulated Depreciation & Amortization stood at $532275.0 in 2021, then grew by 7.0% to $569551.0 in 2022, then soared by 614.57% to $4.1 million in 2023, then grew by 12.92% to $4.6 million in 2024, then rose by 5.9% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Accumulated Depreciation & Amortization are $4.9 million (Q3 2025), $4.8 million (Q2 2025), and $4.6 million (Q4 2024).